| abstract |
The present disclosure relates to biomarkers of cancer and prognostic markers of recurrence in cancer, particularly head and neck squamous cell carcinomas (HNSCC), method of analysing role of said biomarkers/prognostic markers, corresponding methods of detecting cancer and determining/predicting recurrence, and kits thereof. In particular, the present disclosure relates to analyzing aberrations and providing biomarkers of HNSCC and prognostic markers of recurrence in HNSCC and associated methods/applications. Further, said prognostic markers differentiate non-recurring, loco-regionally recurring and distant metastatic tumors. |